TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: VTE occurrence during preoperative chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Pain scores during oocyte retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores after oocyte retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Request for analgesia during oocyte retrieval
Endpoint domain: Adverse events/effects
Primary endpoint: Good functional status at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Survival benefit associated with AFP response
Endpoint domain: Mortality/survival
Primary endpoint: children's outcomes
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Total scores of BERG BALANCE SCALE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total scores of BARTHEL INDEX SCALE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IRF volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ETDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean peripapillary RNFL thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to Discharge (TTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leg extension improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in negative mood
Endpoint domain: Life impact
Endpoint subdomain: emotional functioning/wellbeing
Primary endpoint: Peripheral venous pressure increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Liver stiffness increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to severe CAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: flexion angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Meperidine rescue analgesia administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive complaints on the MOS scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: torsional amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posterior capsule rupture
Endpoint domain: Adverse events/effects
Primary endpoint: iris damage
Endpoint domain: Adverse events/effects
Primary endpoint: internalising problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: externalising problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perseverance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: inflammatory changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dietary restraint and binge-eating behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive accuracy of deep learning-based CP prediction method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: step time variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFC activity while walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attitudes toward the preventability of suicide
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in plasma Lp-PLA2 mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in interleukine-6 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: post‐partum depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of depression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Suicidal ideation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ridge height maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ridge width maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of good outcome based on infarct volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EBV infant infection at week 50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SNAQ score escalation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laxative use frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Onset of optimum sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of buccal midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day patch use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-week cotinine cut-point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels two days after consultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Word contribution during consultations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: latency to dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total surgical time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: microsurgical time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Freedom from incident LAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in pus discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Trunk endurance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee valgus angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip adduction angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excretion fraction of the left parotid gland
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excretion rate of the left parotid gland
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uptake index of the bilateral submandibular glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of LPS-induced TNFα release
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of peripheral neuropathy (PN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of peripheral neuropathy (PN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global health-status/quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of female leaders
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of racial/ethnic minority leaders
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: discharge nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fewer treatment failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daytime systolic/diastolic BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-hour BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fracture rate of crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the clinical score for predicting tympanosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in CAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worst breathlessness improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response rate to NAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum CA125 levels in normal range after NAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sirtuin1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: asleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of postoperative lymphocele
Endpoint domain: Adverse events/effects
Primary endpoint: Vocal handicap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrical activity of infrahyoid muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Temperature difference between supra and infrahyoid regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of DAS28 (CRP) <3.2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: suppression of ucOC and ucOC/tOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning rate for robotic manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean concentration of H2S gas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Halitosis reduction to socially unnoticeable levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of time intragastric pH above 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: very large errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DGR (Daily Growth Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AGR (Average Growth Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FCR (Feed Conversion Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variceal rebleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variceal recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of newly designed label 'poverty' on not starting smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time spent in downhill terrain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent in flat terrain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait speed (25FW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait resistance (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMI flow grading improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TMP grade 3 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac function improvement (CO and LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in CEA and PSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsened redness
Endpoint domain: Adverse events/effects
Primary endpoint: Scar stiffness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scar thickness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Scar irregularity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reductions in opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastroenteritis
Endpoint domain: Adverse events/effects
Primary endpoint: Vision Function Questionnaire (VFQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-year biochemical recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: reduced UC disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-chain fatty acids (SCFAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: muscle temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: power of the first sprint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-exercise recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in width and length of striae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stent expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximum atherectomy area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: first-time failure
Endpoint domain: Mortality/survival
Primary endpoint: ΔVALS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2hPPG < 10 mmol/L while maintaining FPG < 7.2 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility and perception of the SMILE intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time to attach to culture plate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically relevant access-site bleeding or vascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Retention rates in the trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean intervention attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severe events related to the study
Endpoint domain: Adverse events/effects
Primary endpoint: Nociception Level Index (NOL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median chest drain output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived benefit score by participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived benefit score by clinicians
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean VAS score during uterine distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in knowledge about prevention and management of STIs and HIV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in unsafe sexual practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to VLNC cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 8-oxoGuo levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver agreement of cervical dilation measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of cephalic presentation at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Transfusion rate of PRBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Transfusion rate of FFP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fibrinogen administration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of tool utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time taken for risk assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Starting HIV-positive infants on treatment immediately
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in mandibular opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐rated change in psychosocial health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved behavioral intentions for tractor safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achieving RFL within 4 h after the first dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat Free Mass (FFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in reaction times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in No‐Go P3 amplitudes for smoking cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma saturated fatty acids (FAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lung ultrasound scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lung static compliance (Cstat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: postoperative lung atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Heart Rate Variability (HRV) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Confusion index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of loci with decreased sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wasting (weight-for-length Z-score <2 SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of EA (emergence agitation)
Endpoint domain: Adverse events/effects
Primary endpoint: Sessile serrated lesion miss rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PD-L1-IC-positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PD-L1-TC-positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Abnormal scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Penetration of HP into the pulp chamber
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: kinesiophobia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first time out of bed
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: level of observed pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of pro re nata medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Full nerve recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 12-month postoperative scores (DASH, ASES, Constant)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Narcan training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sharing drug equipment frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal oxygen consumption (VO2Max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen consumption at the anaerobic threshold (VO2AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: day-to-day functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Limitation in physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: clinically relevant improvements in health behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps tightness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adequate symptom relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RA disease activity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trial participation acceptance rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: A-S pain prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: A-S pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom increase (ACQ5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who improved their lifestyle
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Impact of enuresis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status